"You can’t control what you can't measure." [Tom DeMarco]
I am strongly believing in people-centric innovation for
drug design and health care. Still, we have serious challenges to solve before this can happen, and a lot of them are
in-vivo, not in-silico:
- Get rid of the negative group dynamics.
- Accept information overload and embrace collaboration.
- Bridge silos, e.g. chemical data silos, but also break-down legal or license hurdles, e.g. by using micropayments.
Please find below the slides and handout for my talk in October on the
BioIT World conference. The conference will cover a large range of life science topics, e.g. -omics, semantics, technology, bioinformatics, life science software, collaboration platform, etc. This is all very exciting and I am looking forward to those talks and meeting people in real life.
Please let me know, if you agree with the challenges, and what you have experienced for using collaboration solutions in a commercial setting. I am a technological geek (tekki), and here I am especially interested in the opinions of the non-tekkis !
Talk to you soon ...
See also
Posts
